MR Imaging in Multiple Sclerosis: Review and Recommendations for Current Practice

被引：71

作者：

Loevblad, K.-O. ^{[1
]}

Anzalone, N. ^{[2
]}

Doerfler, A. ^{[4
]}

Essig, M. ^{[5
]}

Hurwitz, B. ^{[6
]}

Kappos, L. ^{[7
]}

Lee, S. -K. ^{[8
]}

Filippi, M. ^{[3
]}

机构：

[1] Univ Hosp Geneva, Diagnost Neuroradiol Unit, Dept Radiol, CH-1211 Geneva 14, Switzerland

[2] Ist Sci San Raffaele, Dept Neuroradiol, I-20132 Milan, Italy

[3] Ist Sci San Raffaele, Neuroimaging Res Unit, Dept Neurol, I-20132 Milan, Italy

[4] Univ Erlangen Nurnberg, Dept Neuroradiol, Erlangen, Germany

[5] German Canc Res Ctr, Dept Radiol, D-6900 Heidelberg, Germany

[6] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA

[7] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland

[8] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea

来源：

AMERICAN JOURNAL OF NEURORADIOLOGY | 2010年 / 31卷 / 06期

关键词：

NEPHROGENIC SYSTEMIC FIBROSIS; CLINICALLY ISOLATED SYNDROMES; 1ST DEMYELINATING EVENT; CONTRAST AGENTS; GADOBENATE-DIMEGLUMINE; DIAGNOSTIC-CRITERIA; GLATIRAMER ACETATE; ENHANCING LESIONS; DOSE GADOTERIDOL; NATURAL-HISTORY;

D O I：

10.3174/ajnr.A1906

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

MR imaging is widely used for the diagnosis and monitoring of patients with MS. Applications and protocols for MR imaging continue to evolve, prompting a need for continual reassessments of the optimal use of this technique in clinical practice. This article provides updated recommendations on the use of MR imaging in MS, based on a review of the trial evidence and personal experiences shared at a recent expert meeting of radiologists and neurologists.

引用

页码：983 / 989

页数：7

共 58 条

[1] MRI in multiple sclerosis: current status and future prospects [J].

Bakshi, Rohit ;

Thompson, Alan J. ;

Rocca, Maria A. ;

Pelletier, Daniel ;

Dousset, Vincent ;

Barkhof, Frederik ;

Inglese, Matilde ;

Guttmann, Charles R. G. ;

Horsfield, Mark A. ;

Filippi, Massimo .

LANCET NEUROLOGY, 2008, 7 (07) :615-625

[2] Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis [J].

Barkhof, F ;

Filippi, M ;

Miller, DH ;

Scheltens, P ;

Campi, A ;

Polman, CH ;

Comi, G ;

Ader, HJ ;

Losseff, N ;

Valk, J .

BRAIN, 1997, 120 :2059-2069

[3]

Benner T, 2000, J MAGN RESON IMAGING, V12, P371, DOI 10.1002/1522-2586(200009)12:3<371::AID-JMRI1>3.0.CO

[4]

2-3

[5] Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: Valus of spinal MR imaging [J].

Bot, JCJ ;

Barkhof, F ;

Nijeholt, GLA ;

van Schaardenburg, D ;

Voskuyl, AE ;

Ader, HJ ;

Pijnenburg, JAL ;

Polman, CH ;

Uitdehaag, BMJ ;

Vermeulen, EGJ ;

Castelijns, JA .

RADIOLOGY, 2002, 223 (01) :46-56

[6] A longitudinal study of abnormalities on MRI and disability from multiple sclerosis [J].

Brex, PA ;

Ciccarelli, O ;

O'Riordan, JI ;

Sailer, M ;

Thompson, AJ ;

Miller, DH .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (03) :158-164

[7] CLINICAL NMR IMAGING OF THE BRAIN - 140 CASES [J].

BYDDER, GM ;

STEINER, RE ;

YOUNG, IR ;

HALL, AS ;

THOMAS, DJ ;

MARSHALL, J ;

PALLIS, CA ;

LEGG, NJ .

AMERICAN JOURNAL OF ROENTGENOLOGY, 1982, 139 (02) :215-236

[8]

Chan LL, 2007, ANN ACAD MED SINGAP, V36, P647

[9] MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation" [J].

Charil, Arnaud ;

Yousry, Tarek A. ;

Rovaris, Marco ;

Barkhof, Frederik ;

De Stefano, Nicola ;

Fazekas, Franz ;

Miller, David H. ;

Montalban, Xavier ;

Simon, Jack H. ;

Polman, Chris ;

Filippi, Massimo .

LANCET NEUROLOGY, 2006, 5 (10) :841-852

[10] Effect of early interferon treatment on conversion to definite multiple sclerosis:: a randomised study [J].

Comi, G ;

Filippi, M ;

Barkhof, F ;

Durelli, L ;

Edan, G ;

Fernández, O ;

Hartung, HP ;

Seeldrayers, P ;

Sorensen, PS ;

Rovaris, M ;

Martinelli, V ;

Hommes, OR .

LANCET, 2001, 357 (9268) :1576-1582

← 1 2 3 4 5 6 →